Heart Valve Voice News
03 February 2023
This week, NHS England (NHSE) issued a statement updating guidance on using TAVI to treat severe symptomatic aortic stenosis (AS). In the statement, NHSE confirms that TAVI is an alternative to surgical intervention for patients with severe symptomatic aortic stenosis who are at high surgical risk, and has extended its suitability for those at intermediate or low surgical risk, who meet the detailed inclusion criteria which accompanies the document.
21 April 2023
Earlier this week, I was asked to represent Heart Valve Voice and its patient community at a Westminster Health Forum event on Next Steps for Diagnostics and Medical Devices in England. The event featured stakeholders from across the health space, with policymakers, industry professionals and clinical leaders coming together to share their thoughts and ideas. I was there as a patient to share my experience and talk more broadly about what I have learned from other patients as an advocate for Heart Valve Voice.
14 April 2023
Earlier this month, Clinical Lead for Intervention at Liverpool Heart and Chest Hospital, Dr Clare Appleby, gave a presentation to leading figures in the heart valve disease world about gender inequalities in heart valve disease treatment. Here, Dr Appleby discusses that presentation and looks at how to address inequalities in heart valve disease care.
31 March 2023
In December, a concert was held a few days before Christmas in Rhosygilwen, West Wales, to remember Wyn Lewis, or ‘Wyn the Vet’ as he was known to all. Wyn died of heart valve disease in December 2019, and the evening was held as a celebration of his life.
29 March 2023
Heart Valve Voice is delighted to announce that our 2022 National Education Campaign has won a World Heart Federation Award for Creative Campaign.
28 March 2023
Essex heart patients are the first in the country to benefit from new wearable technology used by hospital staff in a revolutionary procedure.
23 March 2023
On December 7, 2022, the Global Coalition on Aging and the Global Heart Hub convened a cross-sector roundtable of experts from healthcare, patient advocacy, policy organizations, and the private sector to discuss the challenge of heart valve disease in the context of ageing societies and their evolving needs.